Physiology Section, Department of Biochemistry and Physiology, Faculty of Pharmacy and Food Science, University of Barcelona (UB), 08028 Barcelona, Spain.
Nutrition and Food Safety Research Institute (INSA-UB), 08921 Santa Coloma de Gramenet, Spain.
Nutrients. 2021 Aug 27;13(9):2975. doi: 10.3390/nu13092975.
Human milk serves as a model for infant formula providing nutritional solutions for infants not able to receive enough mother's milk. Infant formulas aim to mimic the composition and functionality of human milk by providing ingredients reflecting those of the latest human milk insights, such as prebiotics, probiotics and postbiotics. The aim of this study was to examine the effects of the supplementation with a postbiotic (Lactofidus) and its combination with the prebiotics short-chain galactooligosaccharides (scGOS) and long-chain fructooligosaccharides (lcFOS) in a preclinical model of healthy suckling rats. Pups were supplemented daily with Lactofidus (POST group) and/or scGOS/lcFOS (P+P and PRE groups, respectively). Body weight and fecal consistency were analyzed. At the end of the study, immunoglobulin (Ig) profile, intestinal gene expression, microbiota composition and short chain fatty acid (SCFA) proportion were quantified. The supplementation with all nutritional interventions modulated the Ig profile, but the prebiotic mixture and the postbiotic induced differential effects: whereas scGOS/lcFOS induced softer feces and modulated microbiota composition and SCFA profile, Lactofidus™ upregulated Toll-like receptors gene expression. The use of the combination of scGOS/lcFOS and Lactofidus™ showed the effects observed for the oligosaccharides separately, as well as showing a synergistic impact on animal growth. Thus, the combined use of both products seems to be a good strategy to modulate immune and microbial features in early life.
人乳是婴儿配方奶粉的模型,为无法获得足够母乳的婴儿提供营养解决方案。婴儿配方奶粉旨在通过提供反映最新人乳见解的成分来模拟人乳的组成和功能,例如益生元、益生菌和后生元。本研究旨在检查在后生物(Lactofidus)补充及其与短链半乳糖寡糖(scGOS)和长链果糖寡糖(lcFOS)的预生物组合在健康哺乳大鼠临床前模型中的作用。每天给幼崽补充 Lactofidus(POST 组)和/或 scGOS/lcFOS(P+P 和 PRE 组,分别)。分析体重和粪便稠度。研究结束时,定量了免疫球蛋白(Ig)谱、肠道基因表达、微生物群落组成和短链脂肪酸(SCFA)比例。所有营养干预的补充都调节了 Ig 谱,但益生菌混合物和后生元诱导了不同的效果:尽管 scGOS/lcFOS 诱导了更软的粪便,并调节了微生物群落组成和 SCFA 谱,但 Lactofidus™ 上调了 Toll 样受体基因表达。scGOS/lcFOS 和 Lactofidus™ 的联合使用显示了与寡糖分别观察到的效果,并且对动物生长表现出协同影响。因此,两种产品的联合使用似乎是调节生命早期免疫和微生物特征的一种好策略。